My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$MHK {{ '2016-08-05T17:51:51+0000' | timeago}} • Webcast

$MHK said SG&A as reported was $405MM or 17.5% sales in 2Q16. Marketing investments, mainly in the Ceramic and Flooring North American segments, continued during 2Q16. The company expects the SG&A percent to net sales to decline in 2H16, as spending slows and $MHK leverages its cost better with higher sales.

User RC xNair {{ '2016-10-25T17:04:47+0000' | timeago}}

Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."

User Carlton Davis {{ '2016-10-24T19:31:20+0000' | timeago}}

$COL agreed to buy $BEAV for $6.4 billion in cash and stock. Also Rockwell Collins reported higher 4Q16 earnings on growth in Government Systems and higher revenue in Information Management Services.

User Charles Elliston {{ '2016-10-24T19:15:21+0000' | timeago}}

Wow! What a buzz the $T-$TWX deal is making! Almost everyone from politicians to competitors have come out against this deal. Even Wall Street doesn’t seem to be too thrilled. Both stocks were down today.

User Vishnu Beri {{ '2016-10-24T17:33:28+0000' | timeago}}

Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.

User Vishnu Beri {{ '2016-10-24T17:05:39+0000' | timeago}}

Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.

$BHI {{ '2016-10-25T17:48:37+0000' | timeago}} • Webcast

$BHI believes that oil prices should be in the mid to upper 50s for a sustainable recovery in North America. The company expects that the slight improvement in North American market will continue. Internationally, activity declines and pricing pressure are continuing in the near term with customers controlling their spending, the company said.

$UTX {{ '2016-10-25T17:45:45+0000' | timeago}} • Webcast

$UTX is working with the regulatory authorities on the changes required by the Montreal Protocol Amendment. $UTX is in the process of redesigning several systems. One of the issues that $UTX will face with some of its new refrigeration systems will be the passing on of the costs. From a design and market standpoint, $UTX is positioned well.

$MM {{ '2016-10-25T17:42:15+0000' | timeago}} • Webcast

$MM said it repurchased $2.8Bil of its stock YTD and expects to repurchase $3.5-4.5Bil for FY16. The company also said the repurchase is dependent on capital demands such as M&A and relative value and price of the stock.

$GLW {{ '2016-10-25T17:36:29+0000' | timeago}} • Webcast

$GLW said that on a consolidated basis, the company expects 4Q16 GM to be consistent with 3Q16 at 43%. The company added that this guidance reflects the higher sales it expects in Optical Communications segment and YoverY cost reductions in the Display segment.

$LLY {{ '2016-10-25T17:36:10+0000' | timeago}} • Webcast

$LLY said LARTRUVO is the first FDA approved front-line therapy for soft tissue sarcoma in four decades. It also marks the third product from the company's ImClone acquisition to receive regulatory approval. This is an accelerated approval based on data from the company's Phase II trial.